Skip to content
EN
brief us →

23andMe Holding Co.: control, breach, bankruptcy and the sale of genetic data

23andMe Research Institute (TTAM)

TTAM Research Institute, now 23andMe Research Institute, is a California non-profit public-benefit corporation that Anne Wojcicki created after the March 2025 filing to buy the business, and which she funds and leads. It was the backup bidder to Regeneron, then won with $305 million and bought the shares of a new subsidiary holding the business and the customers' genetic data for $302.5 million in cash, closing on July 14, 2025. It undertook to keep the privacy policy and accepted further protections; after closing the trust disputed which liabilities it had assumed.

published
25 oct 2026
records as of
17 oct 2026
entities
208
sources
112
cite entities.csv

1Formation and the bid

analysisThe court found that Wojcicki created TTAM soon after the Chapter 11 filing to buy the debtors' assets; it is a non-profit public-benefit corporation fully funded by her and her affiliates, with her as chief executive, president and one of three directors. It was named backup bidder when Regeneron won the auction in May 2025, then raised its offer to $305 million and was chosen on June 13, 2025, agreeing to buy substantially all the Chrome debtors' assets for $302.5 million and to sponsor a $2.5 million plan for Lemonaid, which was later sold to another buyer. 1 2 3 4 5

sources in this section

  1. Memorandum opinion on the sale of the debtors' assets to TTAM Research Institute U.S. Bankruptcy Court, E.D. Mo.
  2. Disclosure statement for the joint plan of Chrome Holding Co. and its debtor affiliates, Exhibit 99.2 to Form 8-K U.S. Securities and Exchange Commission (EDGAR) · Aug 2025
  3. Chrome Holding Co. annual report on Form 10-K for the fiscal year ended March 31, 2025 U.S. Securities and Exchange Commission (EDGAR) · 2025
  4. Schedule 13D Amendment No. 13 filed by Anne Wojcicki and affiliates regarding 23andMe Holding Co. U.S. Securities and Exchange Commission (EDGAR) · Jun 2025
  5. Chrome Holding Co. Form 8-K on the Lemonaid stock purchase agreement (event of September 10, 2025) U.S. Securities and Exchange Commission (EDGAR) · Sep 2025

2Terms and approval

analysisThe debtors sold it the shares of NewCo, a subsidiary holding the business, so that no data passed directly. TTAM undertook to keep operations, staff, data access and the petition-date privacy policy, including deletion and opt-out rights, to follow privacy laws even where its non-profit status might excuse it, not to share data with insurers and to form an independent privacy advisory board. The court approved the sale on June 27, 2025, finding the price fair and TTAM a good-faith purchaser and adding that it would remain subject to state genetic-privacy laws; it closed on July 14, 2025, and the debtors stopped using the 23andMe name. 1 2 3 4 5

sources in this section

  1. Disclosure statement for the joint plan of Chrome Holding Co. and its debtor affiliates, Exhibit 99.2 to Form 8-K U.S. Securities and Exchange Commission (EDGAR) · Aug 2025
  2. Court record source · src-049 identified by category only · Court record
  3. Memorandum opinion on the sale of the debtors' assets to TTAM Research Institute U.S. Bankruptcy Court, E.D. Mo.
  4. Court record source · src-040 identified by category only · Court record
  5. Chrome Holding Co. Form 8-K on the Lemonaid stock purchase agreement (event of September 10, 2025) U.S. Securities and Exchange Commission (EDGAR) · Sep 2025

3After the closing

analysisThe states' stipulation of July 2026 expressly excludes the Institute from its release, and the states noted that it had accepted strengthened protections, an advisory board and deletion rights. In January 2026 it applied for administrative payments under the purchase agreement, according to a case summary; the trust argued that it had assumed the Converge invoices, it replied disputing any preclusive effect, and on March 4, 2026 the trust settled with Converge for $6.11 million while keeping a right to seek reimbursement from it. California's appeal against the sale order was dismissed on September 29, 2026, the court finding no clear error in the finding that TTAM bought in good faith. Its group includes TTAM 2.0, LLC and three other LLCs represented by the same firm as Wojcicki. 1 2 3 4 5 6 7

sources in this section

  1. Plan Administration Trust's motion to approve the stipulation with the signatory governmental claimants, with the stipulation Office of the New York State Attorney General (copy of a court filing) · 14 Jul 2026
  2. Minnesota Attorney General press release on the multistate settlement Office of the Minnesota Attorney General · 14 Jul 2026
  3. Colorado Attorney General announcement of the multistate settlement of bankruptcy claims Colorado Department of Law · 14 Jul 2026
  4. Research source · src-050 identified by category only · Research
  5. Court record source · src-049 identified by category only · Court record
  6. Court record source · src-065 identified by category only · Court record
  7. Court opinions collection for Case No. 4:25-bk-40976 U.S. Government Publishing Office (GovInfo)

Recorded connections

cite this dossier

DossierTwist, “23andMe Holding Co.: control, breach, bankruptcy and the sale of genetic data”, dt.024, 25 October 2026, https://dossiertwist.com/dossiers/case-23andme-holding-co/

Free to read, cite and republish with credit under CC BY 4.0: credit “DossierTwist” and link to the dossier.

Data: JSON, CSV and the network graph.

share

We listen to all sides: responses are shown next to the claims they answer. To send a correction or a reply, write to dossiertwist@proton.me.